Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Avisa Diagnostics Inc FOGCF

Avisa Diagnostics Inc. is a clinical-stage medical device company. The Company is engaged in the development of the Allora BreathTest (ABT), a drug/device biomarker technology platform. The Allora BreathTest (ABT) is an ultra-rapid, point-of-care biomarker breath test for the detection and monitoring of bacterial load. ABT enables the ultra-rapid detection of virulent bacterial pathogens... see more

GREY:FOGCF - Post Discussion

Avisa Diagnostics Inc > 1 SHARE FOR EVERY 15 YOU HAVE OF NEW COMPANY .
View:
Post by frewil11 on Feb 09, 2021 12:27pm

1 SHARE FOR EVERY 15 YOU HAVE OF NEW COMPANY .

The Consolidation

Immediately prior to the completion of the Transaction, it is a condition that the Company consolidate its issued and outstanding share capital on the basis of fifteen (15) pre-consolidation FogChain Shares for one (1) post-consolidation FogChain Share (the " Consolidation "). The FogChain Shares to be issued to Avisa in connection with the Transaction will be issued on a post-Consolidation basis.

The FogChain Shares issued in connection with the Transaction may be subject to escrow conditions and/or resale restrictions as required by applicable securities laws and the policies of the CSE.

Comment by Diomio on Feb 10, 2021 3:46pm
78mil shares will be 5.2mil shares after the consolidation. so the stock price should open at 0.055 x .15 = .82 cents but if they open with crazy news, covid testing machine.. might be 2$ who knows
Comment by 420sleep on Feb 11, 2021 9:52am
If there ends up only being 5-6 million shares there will be no liquidity!  Wouldn't be surprised if they try to do a PP at that point. 
Comment by Diomio on Feb 12, 2021 1:27pm
plus the 33,263,123 common shares and 14,825,786 restricted voting shares in the capital of the Company (the " FogChain Shares ") on a post-Consolidation so prolly 40mil shares outstanding
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities